Private equity firm ChrysCapital is buying a 10% stake in Hyderabad-based contract research company GVK Biosciences for about $25 million, as per a report in The Times of India.
Register now to enjoy 3 free articles per month,
or log in to continue reading.
Stay informed with complimentary articles each month
Gain access to our exclusive newsletters delivered directly to your inbox
Be the first to know about all our summits!
Already a Subscriber? Log in
